Biolase, Inc. (BIOL): Price and Financial Metrics

BIOL POWR Grades

• BIOL scores best on the Growth dimension, with a Growth rank ahead of 95.62% of US stocks.
• BIOL's strongest trending metric is Sentiment; it's been moving up over the last 36 weeks.
• BIOL's current lowest rank is in the Stability metric (where it is better than 5.21% of US stocks).

BIOL Stock Summary

• With a market capitalization of $102,055,671, Biolase Inc has a greater market value than only 13.29% of US stocks.
• The volatility of Biolase Inc's share price is greater than that of 87.74% US stocks with at least 200 days of trading history.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for BIOL comes in at -28.21% -- higher than that of just 9.95% of stocks in our set.
• Stocks that are quantitatively similar to BIOL, based on their financial statements, market capitalization, and price volatility, are XENT, AXGN, ATRC, STIM, and XXII.
• BIOL's SEC filings can be seen here. And to visit Biolase Inc's official web site, go to www.biolase.com.

BIOL Valuation Summary

• In comparison to the median Healthcare stock, BIOL's price/sales ratio is 5.26% lower, now standing at 3.6.
• BIOL's price/sales ratio has moved down 1.7 over the prior 243 months.
• Over the past 243 months, BIOL's price/earnings ratio has gone up 17.2.

Below are key valuation metrics over time for BIOL.

BIOL Growth Metrics

• The year over year revenue growth rate now stands at -19.04%.
• Its 3 year cash and equivalents growth rate is now at -52.13%.
• Its 2 year cash and equivalents growth rate is now at -79.12%.

BIOL's revenue has moved up $53,000 over the prior 15 months.

The table below shows BIOL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	32.309	-13.464	-13.733
2021-03-31	26.113	-15.16	-17.728
2020-12-31	22.78	-12.795	-16.829
2020-09-30	24.442	-16.119	-14.278
2020-06-30	26.549	-15.458	-19.768
2020-03-31	32.256	-11.846	-18.97

BIOL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BIOL has a Quality Grade of D, ranking ahead of 24.63% of graded US stocks.
• BIOL's asset turnover comes in at 0.622 -- ranking 66th of 182 Medical Equipment stocks.
• TCMD, XENT, and KRMD are the stocks whose asset turnover ratios are most correlated with BIOL.

The table below shows BIOL's key quality metrics over time.